T1 Biomarker 1026 1048 low-dose Dihydralazine
T3 Intervention 897 913 peripheral blood
T4 Biomarker 928 941 Dihydralazine
T6 Intervention 312 318 kidney
T7 Intervention 447 462 kidney fibrosis
T8 Biomarker 1035 1048 Dihydralazine
T9 Disease 15 37 chronic kidney disease
T10 Biomarker 166 178 promoter CpG
T11 Biomarker 1205 1218 Dihydralazine
T12 Intervention 660 666 kidney
T13 Disease 304 326 chronic kidney disease
T14 Gene 509 538 RASAL1 promoter DNA fragments
T15 Intervention 23 29 kidney
T16 Gene 382 407 Ras-GTP suppressor RASAL1
T17 Biomarker 1579 1601 low-dose Dihydralazine
T18 Gene 509 524 RASAL1 promoter
T20 Level 1067 1083 excretory kidney
T21 Organism 955 963 patients
T22 Gene 864 893 RASAL1 promoter DNA fragments
T23 Biomarker 175 178 CpG
T24 Biomarker 735 738 CpG
T25 Intervention 542 558 peripheral blood
T26 Intervention 648 656 fibrosis
T27 Biomarker 1391 1406 counterbalances
T28 Organism 1605 1613 patients
T29 Biomarker 1258 1289 Tdg-mediated DNA-de-methylation
T30 Intervention 1627 1633 kidney
T31 Intervention 660 675 kidney biopsies
T32 Gene 864 879 RASAL1 promoter
T33 Condition 798 826 hypertensive nephrosclerosis
T34 Biomarker 1102 1115 Dihydralazine
T35 Intervention 1520 1534 renal fibrosis
T36 Gene 1449 1464 RASAL1 promoter
T37 Gene 251 256 genes
T41 Disease 1619 1641 chronic kidney disease
T42 Biomarker 1318 1330 promoter CpG
T44 Organism 784 792 patients
T45 Biomarker 1253 1257 Tet3
T46 Intervention 447 453 kidney
T47 Gene 606 621 RASAL1 promoter
T48 Intervention 1646 1654 fibrosis
